Comparing Outcomes of Thrombectomy Versus Intravenous Thrombolysis Based on Middle Cerebral Artery M2 Occlusion Features.
Huan Zhou, Wansi Zhong, Tingxia Zhang...
https://pubmed.ncbi.nlm.nih.gov/38787930Actively Recruiting
Led by Second Affiliated Hospital, School of Medicine, Zhejiang University · Updated on 2022-11-23
200000
Participants Needed
1
Research Sites
52 weeks
Total Duration
S
Second Affiliated Hospital, School of Medicine, Zhejiang University
Lead Sponsor
S
Shaoxing People's Hospital
Collaborating Sponsor
The burden of stroke has increased significantly in China over the past 30 years, making it the leading cause of death. Researchers aim to improve data collection and medical quality management by creating an online database for acute stroke patients. This prospective multi-center study focuses on patients with acute ischemic stroke who receive reperfusion therapy and are hospitalized for stroke treatment. Data from these patients are collected through an emergency platform and a stroke medical quality control platform. The information recorded includes demographics, risk factors such as hypertension, diabetes, and atrial fibrillation, prior antiplatelet use, timing from stroke onset to hospital arrival, baseline stroke severity scores, infarct volume, and laboratory results. The study also provides education to participating centers to help clinicians improve medical quality. Participants' clinical outcomes are assessed at 3 months and 1 year, focusing on independence measured by the modified Rankin Scale (mRS). Additional outcomes include mortality, brain hemorrhage occurrence shortly after hospitalization, and the incidence of recurrent stroke or other vascular events at 1 and 5 years. The study is observational and involves no experimental treatment, lasting several years to track long-term outcomes.
CONDITIONS
Computer-based Online Database of Acute Stroke Patients for Stroke Management Quality Evaluation
You may qualify if you...
You will not qualify if you...
Complete this quick 3-step screening to check your eligibility
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Up to 5 years
Participants who undergo routine care are observed and data related to their stroke treatment and recovery are collected.
Assessments at hospitalization, 3 months, 1 year, and 5 years
Total: 1 location
1
Min Lou
Hangzhou, Zhejiang, China, 310000
Actively Recruiting
M
Min Lou, PhD
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Have more questions? Get in touch with our team for quick support
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Huan Zhou, Wansi Zhong, Tingxia Zhang...
https://pubmed.ncbi.nlm.nih.gov/38787930Rui Xue, Wansi Zhong, Ying Zhou...
https://pubmed.ncbi.nlm.nih.gov/36533622Jianan Wang, Jungen Zhang, Xiaoxian Gong...
https://pubmed.ncbi.nlm.nih.gov/34702747